BriaCell Therapeutics Corp. reported earnings of -$ 1.24 per BCTX share on Oct 28, 2026,Meanwhile, the company posted an EPS of -$ 4.77 during the same period last year, marking a
| Report Date | Oct 28, 2026 |
|---|---|
| Earnings Per Share (Surprise) | -$ 1.24 |
| Last Year's EPS | -$ 4.77 |
| EPS YoY Change |
Out of the last 71 earnings reporting periods, BriaCell Therapeutics Corp. beat analysts’ expectations 7 times and fell short of expectations 10 time(s). BriaCell Therapeutics Corp. reported earnings per share of -$ 1.24 in the last report.
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Oct 28, 2026 | - | -$ 1.24 | -$ 10.49 | |
| Jun 9, 2026 | - | -$ 0.99 | -$ 1.64 | |
| Mar 10, 2026 | -$ 4.84 | -$ 2.58 | -$ 23.30 | |
| Dec 11, 2025 | -$ 3.28 | -$ 4.35 | -$ 32.98 | |
| Oct 27, 2025 | -$ 12.11 | -$ 10.49 | -$ 0.07 | |
| Jun 16, 2025 | -$ 17.60 | -$ 1.64 | -$ 0.73 | |
| Mar 12, 2025 | -$ 19.40 | -$ 23.30 | $ 16.49 | |
| Dec 16, 2024 | -$ 0.30 | -$ 32.98 | -$ 10.64 | |
| Oct 28, 2024 | -$ 0.52 | -$ 0.07 | -$ 0.50 | |
| Jul 31, 2024 | - | -$ 0.73 | -$ 22.49 | |
| Jun 14, 2024 | -$ 0.55 | $ 16.49 | -$ 1.70 | |
| Mar 18, 2024 | -$ 0.20 | -$ 10.64 | -$ 47.98 | |
| Dec 14, 2023 | -$ 0.18 | -$ 0.50 | -$ 0.77 | |
| Oct 25, 2023 | -$ 0.40 | -$ 22.49 | -$ 0.07 | |
| Jul 31, 2023 | - | -$ 1.70 | -$ 0.44 | |
| Jun 14, 2023 | -$ 53.97 | -$ 47.98 | -$ 0.32 | |
| Mar 15, 2023 | -$ 0.37 | -$ 0.77 | -$ 35.98 | |
| Dec 14, 2022 | -$ 0.33 | -$ 0.07 | -$ 22.49 | |
| Jul 5, 2022 | -$ 0.19 | -$ 0.44 | -$ 20.20 | |
| Jun 13, 2022 | -$ 0.19 | -$ 0.32 | -$ 2,735.77 |
BriaCell Therapeutics Corp.’s stock was trading at $ 3.56 on Oct 27, 2026 a day before the last earnings report was released.Following the release of the earnings report, BCTX’s price decreased to $ 3.31 on Oct 29, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Oct 28, 2026 | -$ 1.24 | $ 3.56 | $ 3.31 | |
| Jun 9, 2026 | -$ 0.99 | $ 3.09 | $ 2.88 | |
| Mar 10, 2026 | -$ 2.58 | $ 3.76 | $ 4.34 | |
| Dec 11, 2025 | -$ 4.35 | $ 11.31 | $ 9.54 | |
| Oct 27, 2025 | -$ 10.49 | $ 13.79 | $ 13.34 | |
| Jun 16, 2025 | -$ 1.64 | $ 31.20 | $ 31.20 | |
| Mar 12, 2025 | -$ 23.30 | $ 36.60 | $ 34.50 | |
| Dec 16, 2024 | -$ 32.98 | $ 99.00 | $ 96.84 | |
| Oct 28, 2024 | -$ 0.07 | $ 130.05 | $ 124.85 | |
| Jul 31, 2024 | -$ 0.73 | $ 110.25 | $ 108.83 | |
| Jun 14, 2024 | $ 16.49 | $ 204.00 | $ 222.00 | |
| Mar 18, 2024 | -$ 10.64 | $ 442.50 | $ 406.50 | |
| Dec 14, 2023 | -$ 0.50 | $ 613.80 | $ 619.50 | |
| Oct 25, 2023 | -$ 22.49 | $ 741.00 | $ 651.00 | |
| Jul 31, 2023 | -$ 1.70 | $ 940.50 | $ 1,020.00 | |
| Jun 14, 2023 | -$ 47.98 | $ 862.50 | $ 909.00 | |
| Mar 15, 2023 | -$ 0.77 | $ 1,050.00 | $ 1,075.50 | |
| Dec 14, 2022 | -$ 0.07 | $ 883.50 | $ 843.00 | |
| Jul 5, 2022 | -$ 0.44 | $ 912.00 | $ 892.50 | |
| Jun 13, 2022 | -$ 0.32 | $ 927.00 | $ 879.00 |
BriaCell Therapeutics Corp. released its most recent earnings reports in October 2026, June 2026, March 2026, December 2025 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
